Global Hemato Oncology Testing Market Size, Status and Forecast 2021-2027

Hemato Oncology Testing refers to the detection of common hematological tumors such as leukemia, multiple myeloma, and malignant lymphoma by means of analytical kits, etc.

 

 

The global Hemato Oncology Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

 

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemato Oncology Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemato Oncology Testing market in terms of revenue.

 

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemato Oncology Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemato Oncology Testing market.

 

 

Hemato Oncology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemato Oncology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

 

Segment by Type

Leukemia Testing

Acute Myeloid Testing

Multiple Myeloma Testing

Other

 

Segment by Application

Clinical Laboratories

Hospitals

 

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

 

BY COMPANY

F. Hoffmann-La Roche

Abbott Laboratories

Thermo Fisher Scientific

QIAGEN N.V.

Bio-Rad Laboratories

Illumina

MolecularMD

Invivoscribe

Asuragen

Adaptive Biotechnologies

ArcherDx

ARUP Laboratories

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Leukemia Testing

1.2.3 Acute Myeloid Testing

1.2.4 Multiple Myeloma Testing

1.2.5 Other

1.3 Market by Application

1.3.1 Global Hemato Oncology Testing Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Clinical Laboratories

1.3.3 Hospitals

1.4 Study Objectives

1.5 Years Considered

2.1 Global Hemato Oncology Testing Market Perspective (2016-2027)

2.2 Hemato Oncology Testing Growth Trends by Regions

2.2.1 Hemato Oncology Testing Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2016-2021)

2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2022-2027)

2.3 Hemato Oncology Testing Industry Dynamic

2.3.1 Hemato Oncology Testing Market Trends

2.3.2 Hemato Oncology Testing Market Drivers

2.3.3 Hemato Oncology Testing Market Challenges

2.3.4 Hemato Oncology Testing Market Restraints

3.1 Global Top Hemato Oncology Testing Players by Revenue

3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2016-2021)

3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2016-2021)

3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Hemato Oncology Testing Revenue

3.4 Global Hemato Oncology Testing Market Concentration Ratio

3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2020

3.5 Hemato Oncology Testing Key Players Head office and Area Served

3.6 Key Players Hemato Oncology Testing Product Solution and Service

3.7 Date of Enter into Hemato Oncology Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Hemato Oncology Testing Historic Market Size by Type (2016-2021)

4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2022-2027)

5.1 Global Hemato Oncology Testing Historic Market Size by Application (2016-2021)

5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2022-2027)

6.1 North America Hemato Oncology Testing Market Size (2016-2027)

6.2 North America Hemato Oncology Testing Market Size by Type

6.2.1 North America Hemato Oncology Testing Market Size by Type (2016-2021)

6.2.2 North America Hemato Oncology Testing Market Size by Type (2022-2027)

6.2.3 North America Hemato Oncology Testing Market Size by Type (2016-2027)

6.3 North America Hemato Oncology Testing Market Size by Application

6.3.1 North America Hemato Oncology Testing Market Size by Application (2016-2021)

6.3.2 North America Hemato Oncology Testing Market Size by Application (2022-2027)

6.3.3 North America Hemato Oncology Testing Market Size by Application (2016-2027)

6.4 North America Hemato Oncology Testing Market Size by Country

6.4.1 North America Hemato Oncology Testing Market Size by Country (2016-2021)

6.4.2 North America Hemato Oncology Testing Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Hemato Oncology Testing Market Size (2016-2027)

7.2 Europe Hemato Oncology Testing Market Size by Type

7.2.1 Europe Hemato Oncology Testing Market Size by Type (2016-2021)

7.2.2 Europe Hemato Oncology Testing Market Size by Type (2022-2027)

7.2.3 Europe Hemato Oncology Testing Market Size by Type (2016-2027)

7.3 Europe Hemato Oncology Testing Market Size by Application

7.3.1 Europe Hemato Oncology Testing Market Size by Application (2016-2021)

7.3.2 Europe Hemato Oncology Testing Market Size by Application (2022-2027)

7.3.3 Europe Hemato Oncology Testing Market Size by Application (2016-2027)

7.4 Europe Hemato Oncology Testing Market Size by Country

7.4.1 Europe Hemato Oncology Testing Market Size by Country (2016-2021)

7.4.2 Europe Hemato Oncology Testing Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Hemato Oncology Testing Market Size (2016-2027)

8.2 Asia-Pacific Hemato Oncology Testing Market Size by Type

8.2.1 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Hemato Oncology Testing Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2027)

8.3 Asia-Pacific Hemato Oncology Testing Market Size by Application

8.3.1 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Hemato Oncology Testing Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2027)

8.4 Asia-Pacific Hemato Oncology Testing Market Size by Region

8.4.1 Asia-Pacific Hemato Oncology Testing Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Hemato Oncology Testing Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Hemato Oncology Testing Market Size (2016-2027)

9.2 Latin America Hemato Oncology Testing Market Size by Type

9.2.1 Latin America Hemato Oncology Testing Market Size by Type (2016-2021)

9.2.2 Latin America Hemato Oncology Testing Market Size by Type (2022-2027)

9.2.3 Latin America Hemato Oncology Testing Market Size by Type (2016-2027)

9.3 Latin America Hemato Oncology Testing Market Size by Application

9.3.1 Latin America Hemato Oncology Testing Market Size by Application (2016-2021)

9.3.2 Latin America Hemato Oncology Testing Market Size by Application (2022-2027)

9.3.3 Latin America Hemato Oncology Testing Market Size by Application (2016-2027)

9.4 Latin America Hemato Oncology Testing Market Size by Country

9.4.1 Latin America Hemato Oncology Testing Market Size by Country (2016-2021)

9.4.2 Latin America Hemato Oncology Testing Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Hemato Oncology Testing Market Size (2016-2027)

10.2 Middle East & Africa Hemato Oncology Testing Market Size by Type

10.2.1 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Hemato Oncology Testing Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2027)

10.3 Middle East & Africa Hemato Oncology Testing Market Size by Application

10.3.1 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Hemato Oncology Testing Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2027)

10.4 Middle East & Africa Hemato Oncology Testing Market Size by Country

10.4.1 Middle East & Africa Hemato Oncology Testing Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Hemato Oncology Testing Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 F. Hoffmann-La Roche

11.1.1 F. Hoffmann-La Roche Company Details

11.1.2 F. Hoffmann-La Roche Business Overview

11.1.3 F. Hoffmann-La Roche Hemato Oncology Testing Introduction

11.1.4 F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2016-2021)

11.1.5 F. Hoffmann-La Roche Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Hemato Oncology Testing Introduction

11.2.4 Abbott Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)

11.2.5 Abbott Laboratories Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Hemato Oncology Testing Introduction

11.3.4 Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2016-2021)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 QIAGEN N.V.

11.4.1 QIAGEN N.V. Company Details

11.4.2 QIAGEN N.V. Business Overview

11.4.3 QIAGEN N.V. Hemato Oncology Testing Introduction

11.4.4 QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2016-2021)

11.4.5 QIAGEN N.V. Recent Development

11.5 Bio-Rad Laboratories

11.5.1 Bio-Rad Laboratories Company Details

11.5.2 Bio-Rad Laboratories Business Overview

11.5.3 Bio-Rad Laboratories Hemato Oncology Testing Introduction

11.5.4 Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)

11.5.5 Bio-Rad Laboratories Recent Development

11.6 Illumina

11.6.1 Illumina Company Details

11.6.2 Illumina Business Overview

11.6.3 Illumina Hemato Oncology Testing Introduction

11.6.4 Illumina Revenue in Hemato Oncology Testing Business (2016-2021)

11.6.5 Illumina Recent Development

11.7 MolecularMD

11.7.1 MolecularMD Company Details

11.7.2 MolecularMD Business Overview

11.7.3 MolecularMD Hemato Oncology Testing Introduction

11.7.4 MolecularMD Revenue in Hemato Oncology Testing Business (2016-2021)

11.7.5 MolecularMD Recent Development

11.8 Invivoscribe

11.8.1 Invivoscribe Company Details

11.8.2 Invivoscribe Business Overview

11.8.3 Invivoscribe Hemato Oncology Testing Introduction

11.8.4 Invivoscribe Revenue in Hemato Oncology Testing Business (2016-2021)

11.8.5 Invivoscribe Recent Development

11.9 Asuragen

11.9.1 Asuragen Company Details

11.9.2 Asuragen Business Overview

11.9.3 Asuragen Hemato Oncology Testing Introduction

11.9.4 Asuragen Revenue in Hemato Oncology Testing Business (2016-2021)

11.9.5 Asuragen Recent Development

11.10 Adaptive Biotechnologies

11.10.1 Adaptive Biotechnologies Company Details

11.10.2 Adaptive Biotechnologies Business Overview

11.10.3 Adaptive Biotechnologies Hemato Oncology Testing Introduction

11.10.4 Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2016-2021)

11.10.5 Adaptive Biotechnologies Recent Development

11.11 ArcherDx

11.11.1 ArcherDx Company Details

11.11.2 ArcherDx Business Overview

11.11.3 ArcherDx Hemato Oncology Testing Introduction

11.11.4 ArcherDx Revenue in Hemato Oncology Testing Business (2016-2021)

11.11.5 ArcherDx Recent Development

11.12 ARUP Laboratories

11.12.1 ARUP Laboratories Company Details

11.12.2 ARUP Laboratories Business Overview

11.12.3 ARUP Laboratories Hemato Oncology Testing Introduction

11.12.4 ARUP Laboratories Revenue in Hemato Oncology Testing Business (2016-2021)

11.12.5 ARUP Laboratories Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Leukemia Testing

    Table 3. Key Players of Acute Myeloid Testing

    Table 4. Key Players of Multiple Myeloma Testing

    Table 5. Key Players of Other

    Table 6. Global Hemato Oncology Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 7. Global Hemato Oncology Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 8. Global Hemato Oncology Testing Market Size by Regions (2016-2021) & (US$ Million)

    Table 9. Global Hemato Oncology Testing Market Share by Regions (2016-2021)

    Table 10. Global Hemato Oncology Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 11. Global Hemato Oncology Testing Market Share by Regions (2022-2027)

    Table 12. Hemato Oncology Testing Market Trends

    Table 13. Hemato Oncology Testing Market Drivers

    Table 14. Hemato Oncology Testing Market Challenges

    Table 15. Hemato Oncology Testing Market Restraints

    Table 16. Global Hemato Oncology Testing Revenue by Players (2016-2021) & (US$ Million)

    Table 17. Global Hemato Oncology Testing Market Share by Players (2016-2021)

    Table 18. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2020)

    Table 19. Ranking of Global Top Hemato Oncology Testing Companies by Revenue (US$ Million) in 2020

    Table 20. Global 5 Largest Players Market Share by Hemato Oncology Testing Revenue (CR5 and HHI) & (2016-2021)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Hemato Oncology Testing Product Solution and Service

    Table 23. Date of Enter into Hemato Oncology Testing Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 26. Global Hemato Oncology Testing Revenue Market Share by Type (2016-2021)

    Table 27. Global Hemato Oncology Testing Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 28. Global Hemato Oncology Testing Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 29. Global Hemato Oncology Testing Market Size Share by Application (2016-2021) & (US$ Million)

    Table 30. Global Hemato Oncology Testing Revenue Market Share by Application (2016-2021)

    Table 31. Global Hemato Oncology Testing Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 32. Global Hemato Oncology Testing Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 33. North America Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 34. North America Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)

    Table 35. North America Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)

    Table 36. North America Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 37. North America Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 38. North America Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 39. Europe Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 40. Europe Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)

    Table 41. Europe Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)

    Table 42. Europe Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 43. Europe Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 44. Europe Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)

    Table 48. Asia-Pacific Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 49. Asia-Pacific Hemato Oncology Testing Market Size by Region (2016-2021) & (US$ Million)

    Table 50. Asia-Pacific Hemato Oncology Testing Market Size by Region (2022-2027) & (US$ Million)

    Table 51. Latin America Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 52. Latin America Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)

    Table 53. Latin America Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)

    Table 54. Latin America Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 55. Latin America Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 56. Latin America Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Hemato Oncology Testing Market Size by Type (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021) (US$ Million)

    Table 60. Middle East & Africa Hemato Oncology Testing Market Size by Application (2022-2027) & (US$ Million)

    Table 61. Middle East & Africa Hemato Oncology Testing Market Size by Country (2016-2021) & (US$ Million)

    Table 62. Middle East & Africa Hemato Oncology Testing Market Size by Country (2022-2027) & (US$ Million)

    Table 63. F. Hoffmann-La Roche Company Details

    Table 64. F. Hoffmann-La Roche Business Overview

    Table 65. F. Hoffmann-La Roche Hemato Oncology Testing Product

    Table 66. F. Hoffmann-La Roche Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 67. F. Hoffmann-La Roche Recent Development

    Table 68. Abbott Laboratories Company Details

    Table 69. Abbott Laboratories Business Overview

    Table 70. Abbott Laboratories Hemato Oncology Testing Product

    Table 71. Abbott Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 72. Abbott Laboratories Recent Development

    Table 73. Thermo Fisher Scientific Company Details

    Table 74. Thermo Fisher Scientific Business Overview

    Table 75. Thermo Fisher Scientific Hemato Oncology Testing Product

    Table 76. Thermo Fisher Scientific Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 77. Thermo Fisher Scientific Recent Development

    Table 78. QIAGEN N.V. Company Details

    Table 79. QIAGEN N.V. Business Overview

    Table 80. QIAGEN N.V. Hemato Oncology Testing Product

    Table 81. QIAGEN N.V. Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 82. QIAGEN N.V. Recent Development

    Table 83. Bio-Rad Laboratories Company Details

    Table 84. Bio-Rad Laboratories Business Overview

    Table 85. Bio-Rad Laboratories Hemato Oncology Testing Product

    Table 86. Bio-Rad Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 87. Bio-Rad Laboratories Recent Development

    Table 88. Illumina Company Details

    Table 89. Illumina Business Overview

    Table 90. Illumina Hemato Oncology Testing Product

    Table 91. Illumina Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 92. Illumina Recent Development

    Table 93. MolecularMD Company Details

    Table 94. MolecularMD Business Overview

    Table 95. MolecularMD Hemato Oncology Testing Product

    Table 96. MolecularMD Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 97. MolecularMD Recent Development

    Table 98. Invivoscribe Company Details

    Table 99. Invivoscribe Business Overview

    Table 100. Invivoscribe Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 101. Invivoscribe Recent Development

    Table 102. Asuragen Company Details

    Table 103. Asuragen Business Overview

    Table 104. Asuragen Hemato Oncology Testing Product

    Table 105. Asuragen Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 106. Asuragen Recent Development

    Table 107. Adaptive Biotechnologies Company Details

    Table 108. Adaptive Biotechnologies Business Overview

    Table 109. Adaptive Biotechnologies Hemato Oncology Testing Product

    Table 110. Adaptive Biotechnologies Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 111. Adaptive Biotechnologies Recent Development

    Table 112. ArcherDx Company Details

    Table 113. ArcherDx Business Overview

    Table 114. ArcherDx Hemato Oncology Testing Product

    Table 115. ArcherDx Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 116. ArcherDx Recent Development

    Table 117. ARUP Laboratories Company Details

    Table 118. ARUP Laboratories Business Overview

    Table 119. ARUP Laboratories Hemato Oncology Testing Product

    Table 120. ARUP Laboratories Revenue in Hemato Oncology Testing Business (2016-2021) & (US$ Million)

    Table 121. ARUP Laboratories Recent Development

    Table 122. Research Programs/Design for This Report

    Table 123. Key Data Information from Secondary Sources

    Table 124. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Hemato Oncology Testing Market Share by Type: 2020 VS 2027

    Figure 2. Leukemia Testing Features

    Figure 3. Acute Myeloid Testing Features

    Figure 4. Multiple Myeloma Testing Features

    Figure 5. Other Features

    Figure 6. Global Hemato Oncology Testing Market Share by Application: 2020 VS 2027

    Figure 7. Clinical Laboratories Case Studies

    Figure 8. Hospitals Case Studies

    Figure 9. Hemato Oncology Testing Report Years Considered

    Figure 10. Global Hemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 11. Global Hemato Oncology Testing Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 12. Global Hemato Oncology Testing Market Share by Regions: 2020 VS 2027

    Figure 13. Global Hemato Oncology Testing Market Share by Regions (2022-2027)

    Figure 14. Global Hemato Oncology Testing Market Share by Players in 2020

    Figure 15. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemato Oncology Testing as of 2020

    Figure 16. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2020

    Figure 17. Global Hemato Oncology Testing Revenue Market Share by Type (2016-2021)

    Figure 18. Global Hemato Oncology Testing Revenue Market Share by Type (2022-2027)

    Figure 19. North America Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 20. North America Hemato Oncology Testing Market Share by Type (2016-2027)

    Figure 21. North America Hemato Oncology Testing Market Share by Application (2016-2027)

    Figure 22. North America Hemato Oncology Testing Market Share by Country (2016-2027)

    Figure 23. United States Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Canada Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. Europe Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 26. Europe Hemato Oncology Testing Market Share by Type (2016-2027)

    Figure 27. Europe Hemato Oncology Testing Market Share by Application (2016-2027)

    Figure 28. Europe Hemato Oncology Testing Market Share by Country (2016-2027)

    Figure 29. Germany Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. France Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. U.K. Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Italy Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Russia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Nordic Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Asia-Pacific Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 36. Asia-Pacific Hemato Oncology Testing Market Share by Type (2016-2027)

    Figure 37. Asia-Pacific Hemato Oncology Testing Market Share by Application (2016-2027)

    Figure 38. Asia-Pacific Hemato Oncology Testing Market Share by Region (2016-2027)

    Figure 39. China Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. Japan Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. South Korea Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. India Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Australia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Latin America Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 46. Latin America Hemato Oncology Testing Market Share by Type (2016-2027)

    Figure 47. Latin America Hemato Oncology Testing Market Share by Application (2016-2027)

    Figure 48. Latin America Hemato Oncology Testing Market Share by Country (2016-2027)

    Figure 49. Mexico Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Brazil Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Middle East & Africa Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 52. Middle East & Africa Hemato Oncology Testing Market Share by Type (2016-2027)

    Figure 53. Middle East & Africa Hemato Oncology Testing Market Share by Application (2016-2027)

    Figure 54. Middle East & Africa Hemato Oncology Testing Market Share by Country (2016-2027)

    Figure 55. Turkey Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. Saudi Arabia Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. UAE Hemato Oncology Testing Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 59. Abbott Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 61. QIAGEN N.V. Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 63. Illumina Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 64. MolecularMD Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 65. Invivoscribe Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 66. Asuragen Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 67. Adaptive Biotechnologies Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 68. ArcherDx Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 69. ARUP Laboratories Revenue Growth Rate in Hemato Oncology Testing Business (2016-2021)

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed